Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study
Condition(s):Demyelinating Sensorimotor NeuropathyLast Updated:October 24, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Demyelinating Sensorimotor NeuropathyLast Updated:October 24, 2023Terminated
Condition(s):Oral UlcerLast Updated:April 7, 2023Recruiting
Condition(s):Advanced HCCLast Updated:April 26, 2023Not yet recruiting
Condition(s):Relapsed and/or Refractory Non-Hodgkin T-cell LymphomaLast Updated:October 22, 2020Unknown status
Condition(s):DermatomyositisLast Updated:August 4, 2022Not yet recruiting
Condition(s):Chronic Lymphocytic Leukemia (CLL)Last Updated:April 28, 2017Withdrawn
Condition(s):Leukemia, Myeloid; Myelodysplastic SyndromesLast Updated:January 27, 2020Terminated
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:January 18, 2018Terminated
Condition(s):Adult T-Cell Leukemia-LymphomaLast Updated:May 29, 2018Completed
Condition(s):Diffuse Large B Cell Lymphoma; Age Over 80 YearsLast Updated:November 10, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.